Suche
Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin
Publikation
Müller L,
Murgia X,
Siebenbürger L,
Börger C,
Schwarzkopf K,
Sewald K,
Häussler S,
Braun A,
Lehr C,
Hittinger M,
Wronski S
(2018)
The Journal of antimicrobial chemotherapy, 73, 10, 2762-2769, 10.1093/jac/dky241, 29982453
The Journal of antimicrobial chemotherapy, 73, 10, 2762-2769, 10.1093/jac/dky241, 29982453
A novel co-culture model of human bronchial epithelial cells and Pseudomonas aeruginosa biofilms to mimic chronic lung infections in cystic fibrosis
Publikation
Juntke J
(2018)
UnpublishedWork, 10.22028/D291-27897
UnpublishedWork, 10.22028/D291-27897
Chemically modified h CFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
Publikation
Haque,
A. K. M. Ashiqul,
Dewerth A,
Antony J,
Riethmüller J,
Schweizer G,
Weinmann P,
Latifi N,
Yasar H,
Pedemonte N,
Sondo E,
Weidensee B,
Ralhan A,
Laval J,
Schlegel P,
Seitz C,
Loretz B,
Lehr C,
Handgretinger R,
Kormann M
(2018)
Scientific Reports, 8, 1, 10.1038/s41598-018-34960-0
Scientific Reports, 8, 1, 10.1038/s41598-018-34960-0
In Vitro Model of the Gram-Negative Bacterial Cell Envelope for Investigation of Anti-Infective Permeation Kinetics
Publikation
Graef F,
Richter R,
Fetz V,
Murgia X,
Rossi C,
Schneider-Daum N,
Allegretta G,
Elgaher W,
Haupenthal J,
Empting M,
Beckmann F,
Brönstrup M,
Hartmann R,
Gordon S,
Lehr C
(2018)
ACS infectious diseases, 4, 8, 1188-1196, 10.1021/acsinfecdis.7b00165, 29750862
ACS infectious diseases, 4, 8, 1188-1196, 10.1021/acsinfecdis.7b00165, 29750862
Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin
Publikation
Ho D,
Costa A,
Rossi C,
Souza Carvalho-Wodarz C,
Loretz B,
Lehr C
(2018)
Molecular pharmaceutics, 15, 3, 1081-1096, 10.1021/acs.molpharmaceut.7b00967, 29425049
Molecular pharmaceutics, 15, 3, 1081-1096, 10.1021/acs.molpharmaceut.7b00967, 29425049
Combining MucilAir™ and Vitrocell® Powder Chamber for the In Vitro Evaluation of Nasal Ointments in the Context of Aerosolized Pollen
Publikation
Metz J,
Knoth K,
Groß H,
Lehr C,
Stäbler C,
Bock U,
Hittinger M
(2018)
Pharmaceutics, 10, 2, 10.3390/pharmaceutics10020056, 29747472
Pharmaceutics, 10, 2, 10.3390/pharmaceutics10020056, 29747472
A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes
Publikation
Serr I,
Scherm M,
Zahm A,
Schug J,
Flynn V,
Hippich M,
Kälin S,
Becker M,
Achenbach P,
Nikolaev A,
Gerlach K,
Liebsch N,
Loretz B,
Lehr C,
Kirchner B,
Spornraft M,
Haase B,
Segars J,
Küper C,
Palmisano R,
Waisman A,
Willis R,
Kim W,
Weigmann B,
Kaestner K,
Ziegler A,
Daniel C
(2018)
Science translational medicine, 10, 422, 10.1126/scitranslmed.aag1782, 29298866
Science translational medicine, 10, 422, 10.1126/scitranslmed.aag1782, 29298866
Establishment of an In Bacterio Assay for the Assessment of Carbon Storage Regulator A (CsrA) Inhibitors
Publikation
Wu Y,
Zoller B,
Kamal M,
Hotop S,
Lehr C,
Brönstrup M,
Dersch P,
Empting M
(2023)
Chembiochem : a European journal of chemical biology, 24, 16, 10.1002/cbic.202300369, 37435861
Chembiochem : a European journal of chemical biology, 24, 16, 10.1002/cbic.202300369, 37435861
Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media
Publikation
Kliesch L,
Delandre S,
Gabelmann A,
Koch M,
Schulze K,
Guzmán C,
Loretz B,
Lehr C
(2022)
Pharmaceutics, 14, 12, 10.3390/pharmaceutics14122675, 36559170
Pharmaceutics, 14, 12, 10.3390/pharmaceutics14122675, 36559170
Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy
Publikation
Arrua E,
Hartwig O,
Loretz B,
Goicoechea H,
Murgia X,
Lehr C,
Salomon C
(2022)
Colloids and surfaces. B, Biointerfaces, 217, 10.1016/j.colsurfb.2022.112678, 35816885
Colloids and surfaces. B, Biointerfaces, 217, 10.1016/j.colsurfb.2022.112678, 35816885